Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, report researchers.

 

sciencedaily

 

e-mail: head_office@nbscience.com

stem cells therapy

Categories: stem cells

NBScience

contract research organization

stem cell therapy